Unlocking yeast’s palette: leveraging metabolomics and gene editing approaches for cost effective carotenoid production

Owing to the soaring demand of sustainable nutraceuticals, cosmetics and pharmaceuticals, the yeast-based carotenoid synthesis has attracted a lot of attention. Yeasts have the inherent capacity to synthesize an array of carotenoids including β-carotene, astaxanthin, lycopene, and zeaxanthin. Exploitation of yeasts for carotenoid production offers a natural and cost-effective solution to meet the growing demand of natural carotenoids. Although wild-type strains naturally synthesize carotenoids, however the low yields, limited metabolic pathways, competition with endogenous pathways, and sensitivity to environmental factors lead to suboptimal production efficiency. Development of engineered strains with high yields and resilience to abiotic and biotic stressors is thus required for commercialization. In this regard, metabolomics analysis of the target yeast cultivated in different conditions can lead to identification of key targets that could be exploited for enhancing the carotenoid synthesis via gene editing. Within the field of metabolomics, techniques like advanced metabolite quantification and flux balance analysis provide in-depth understanding on the yeast’s metabolism and carotenoid biosynthesis. Notably, the use of CRISPR-Cas9 for precise gene editing for reshaping the genotype for maximizing carotenoid productivity is gaining momentum. The methodologies of synthetic biology and the principle of directed evolution additionally enhance the function of enzymes, ligand-binding and regulatory elements, which in turn sustains the equilibrium of the synthesizing pathway at the high level of expression. The present review provides a comprehensive analysis of the carotenoid production using genetic engineered strains. Moreover, the review underscores the transformative potential of metabolomics approaches for identifying novel genetic engineering targets in yeasts. The cost-competitiveness of yeast-based carotenoids along with challenges and future perspectives is also discussed.

Authors

Institutions

Publication Details

Journal
Blue Biotechnology
Published
2025-05-01
DOI
https://doi.org/10.1186/s44315-025-00028-8
Citations
1
Primary Topic
Plant biochemistry and biosynthesis
Type
article
Field-Weighted Citation Impact
0.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Unlocking yeast’s palette: leveraging metabolomics and gene editing approaches for cost effective carotenoid production

Prem Pritam, Neha Arora
1 citations
Blue Biotechnology
Plant biochemistry and biosynthesis
0.81
article

Unlocking yeast’s palette: leveraging metabolomics and gene editing approaches for cost effective carotenoid production

Prem Pritam, Neha Arora
article en
1 citations

Abstract

Owing to the soaring demand of sustainable nutraceuticals, cosmetics and pharmaceuticals, the yeast-based carotenoid synthesis has attracted a lot of attention. Yeasts have the inherent capacity to synthesize an array of carotenoids including β-carotene, astaxanthin, lycopene, and zeaxanthin. Exploitation of yeasts for carotenoid production offers a natural and cost-effective solution to meet the growing demand of natural carotenoids. Although wild-type strains naturally synthesize carotenoids, however the low yields, limited metabolic pathways, competition with endogenous pathways, and sensitivity to environmental factors lead to suboptimal production efficiency. Development of engineered strains with high yields and resilience to abiotic and biotic stressors is thus required for commercialization. In this regard, metabolomics analysis of the target yeast cultivated in different conditions can lead to identification of key targets that could be exploited for enhancing the carotenoid synthesis via gene editing. Within the field of metabolomics, techniques like advanced metabolite quantification and flux balance analysis provide in-depth understanding on the yeast’s metabolism and carotenoid biosynthesis. Notably, the use of CRISPR-Cas9 for precise gene editing for reshaping the genotype for maximizing carotenoid productivity is gaining momentum. The methodologies of synthetic biology and the principle of directed evolution additionally enhance the function of enzymes, ligand-binding and regulatory elements, which in turn sustains the equilibrium of the synthesizing pathway at the high level of expression. The present review provides a comprehensive analysis of the carotenoid production using genetic engineered strains. Moreover, the review underscores the transformative potential of metabolomics approaches for identifying novel genetic engineering targets in yeasts. The cost-competitiveness of yeast-based carotenoids along with challenges and future perspectives is also discussed.

Blue BiotechnologyVol. 2(1)
Skidmore College (US), University of South Florida (US), University of Delaware (US)
Zero hunger
Openalex Percentile: Top 29%
Plant biochemistry and biosynthesis
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.